• Initial year invested: 2022
• Current stage: Series A
• Fintech subsector: HealthTech, InsurTech, Telehealth (Virtual HMO)
• Group 11 involvement: Invested in Series A.

Antidote is a US-based digital health platform offering quality, affordable telehealthcare.